Details about detection of IDH1/2 mutations by CADMA PCR
Chapter Supplement – Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas – a Retrospective, Single-centre Molecular Genetics Study of Gliomas
Vyšlo v časopise:
Klin Onkol 2017; 30(Online only): 1-2
prolekare.web.journal.doi_sk:
https://doi.org/10.14735/amko20171
Zdroje
1. Kristensen LS, Andersen GB, Hager H et al. Competitive amplification of differentially melting amplicons (CADMA) enables sensitive and direct detection of all mutation types by high-resolution melting analysis. Hum Mutat 2012; 33 (1): 264–271. doi: 10.1002/humu.21598.
2. Bustin SA, Benes V, Garson JA et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. ClinChem 2009; 55 (4): 611–622. doi: 10.1373/clinchem.2008.112797.
3. Dwight ZL, Palais R, Kent J et al. Heterozygote PCR product melting curve prediction. Hum Mutat 2014; 35 (3): 278–282. doi: 10.1002/humu.22494.
4. Stranska J, Jancik S, Slavkovsky R et al. Whole genome amplification induced bias in the detection of KRAS-mutated cell populations during colorectal carcinoma tissue testing. Electrophoresis 2015; 36 (6) : 937–940.
Štítky
Detská onkológia Chirurgia všeobecná OnkológiaČlánok vyšiel v časopise
Klinická onkologie
2017 Číslo Online only
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejasný stín na plicích – kazuistika
- MUDr. Dana Vondráčková: Hepatopatie sú pri liečbe metamizolom väčším strašiakom ako agranulocytóza
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
Najčítanejšie v tomto čísle